Vertical: CNMBase Year: 2025
Market Size (2025)
$70.47M
Projected (2032)
$95.42M
CAGR (2022–2032)
4.4%
Key Players
10+
Market Overview
The Global DL-Methionine Market was valued at USD 70.47 million in 2025 and is projected to reach USD 95.42 million by 2032, registering a CAGR of 4.42% over the forecast period 2026–2032. Over the historic period the market expanded from USD 61.87 million in 2022 to USD 67.48 million in 2024, and between 2025 and 2032 it is expected to add USD 24.95 million in absolute value.
DL-methionine is a synthetic, sulfur-containing essential amino acid supplied to the compound feed industry to balance diets for poultry, swine, aquaculture species and other animals. Methionine is typically the first limiting amino acid in corn–soybean meal poultry diets, which makes it one of the highest-volume feed amino acids worldwide. Demand is closely tied to the volume of compound feed produced, the intensity of amino acid supplementation per tonne of feed, and the cost of protein-rich raw materials such as soybean meal and fishmeal that DL-methionine partly replaces.
Growth over the forecast period is supported by rising consumption of poultry meat and eggs in emerging economies, wider adoption of low-crude-protein diets that rely on synthetic amino acids to meet nutrient requirements while reducing nitrogen excretion, and the continued expansion of aquaculture. These drivers are partly offset by cyclical methionine pricing and volatile raw material costs.
Key Findings
By Physical Form: Powder is the largest segment, valued at USD 63.42 million in 2025 and accounting for 90.00% of the market. Liquid is the fastest-growing segment, with a CAGR of 5.83% during 2026–2032.
By Livestock: Poultry is the largest segment, valued at USD 45.81 million in 2025 with a 65.00% share. Aquaculture & Others is the fastest-growing segment, with a CAGR of 5.31%.
By Region: Asia Pacific is the leading region, valued at USD 29.60 million in 2025 (42.00% share). Middle East & Africa is the fastest-growing region, with a CAGR of 5.27%.
By Country: China is the leading country, valued at USD 14.21 million in 2025, while India is the fastest-growing country, with a CAGR of 6.71% during 2026–2032.
Segmentation Summary
The market is segmented by physical form into Powder and Liquid, and by livestock into Poultry, Swine and Aquaculture & Others. Powder DL-methionine, the conventional crystalline product with a purity of at least 99%, remains the dominant form because it is easy to store, ship and blend in premixes and in feed mills of all sizes. Liquid methionine products, which are dosed directly through automated liquid-application systems, are gaining share in large integrated feed mills; the Liquid segment is projected to increase from USD 7.05 million in 2025 to USD 10.52 million in 2032.
Poultry feed is the core end use, reflecting the high methionine requirement of broilers and laying hens for feathering, growth and egg production. Aquaculture & Others, which grows from USD 14.09 million in 2025 to USD 20.30 million in 2032, benefits from the replacement of fishmeal with plant proteins in aquafeeds. Swine, valued at USD 10.57 million in 2025, records the slowest growth, with a CAGR of 3.71%.
Competitive Landscape Summary
The supply side of the market is highly consolidated. A small group of producers with large, chemically integrated plants – Evonik Industries, Adisseo, Novus International and Sumitomo Chemical – has historically supplied most of the world's feed methionine. Chinese producers, notably Zhejiang NHU, Sichuan Hebang and Ningxia Unisplendour Tianhua, have added substantial capacity since the early 2020s, while CJ CheilJedang supplies fermentation-based L-methionine that competes directly with DL-methionine in feed applications. Competition centres on production cost, backward integration into key intermediates, reliability of supply, technical service to feed formulators and the breadth of powder, liquid and specialty methionine portfolios.
Challenges and Opportunities
The principal challenges are the volatility of petrochemical inputs such as propylene, methanol, natural gas and sulfur; the hazardous nature of intermediates including acrolein, hydrogen cyanide and methyl mercaptan, which raises safety and compliance costs; and the risk of oversupply as new capacity in China comes on stream. In 2026, disruptions to raw material supply linked to the conflict in the Middle East tightened availability, and producers announced successive price increases.
Opportunities arise from the expansion of aquaculture and of commercial poultry production in South and Southeast Asia, Latin America and Africa; the conversion of large feed mills to liquid dosing systems; the growing role of amino acids in low-protein, lower-emission feeding strategies; and demand for rumen-protected methionine in dairy nutrition.
Future Outlook
The Global DL-Methionine Market is expected to grow steadily from USD 73.60 million in 2026 to USD 95.42 million in 2032. Asia Pacific will remain the largest regional market, rising to USD 41.66 million by 2032, and will contribute USD 12.06 million of incremental value between 2025 and 2032, the largest absolute gain of any region. Liquid forms and the Aquaculture & Others segment will outpace the overall market, while Powder and Poultry will continue to account for the bulk of demand.
The DL-Methionine Market market is projected to grow at a CAGR of 4.4% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
DL-methionine (2-amino-4-(methylthio)butanoic acid, C5H11NO2S) is the racemic mixture of the D- and L-isomers of methionine, an essential sulfur-containing amino acid that animals cannot synthesise and must obtain from feed. Monogastric animals convert the D-isomer to the biologically active L-form, so DL-methionine is used as a fully available source of methionine in compound feed. Methionine supports protein synthesis, feather and muscle growth, egg production and immune function, and serves as a methyl-group donor and precursor of cysteine.
Industrially, DL-methionine is produced by chemical synthesis. Propylene is converted to acrolein, which reacts with methyl mercaptan to form 3-(methylthio)propionaldehyde (MMP); MMP is converted with hydrogen cyanide and ammonia/carbon dioxide into a hydantoin intermediate, which is hydrolysed and crystallised to DL-methionine. The same MMP intermediate is used to make methionine hydroxy analogue (HMTBa), the main liquid methionine source.
For the purpose of this study, the market includes:
Feed-grade DL-methionine in powder (crystalline) form, typically with a purity of 99% or higher, including products used in premixes, concentrates and complete feeds
Liquid methionine products used as methionine sources in feed, including methionine hydroxy analogue free acid solutions and liquid sodium DL-methioninate
Use in poultry, swine, aquaculture and other animal feeds, including ruminant and pet food applications grouped under Aquaculture & Others
The market excludes methionine used in pharmaceutical, infusion, cosmetic and human food applications; other feed amino acids such as lysine, threonine, tryptophan and valine; and methionine contained naturally in feed raw materials such as soybean meal and fishmeal.
Scope of the Study
The study covers the global DL-methionine market, analysed by the following segmentations and geographies:
By Physical Form: Powder; Liquid
By Livestock: Poultry; Swine; Aquaculture & Others
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA)
Timeline: historic years 2022–2024, base year 2025 and forecast years 2026–2032, with CAGR presented for 2026–2032
Unit: all values are presented in USD Million
Research Objectives
To estimate the size of the global DL-methionine market in value terms for 2022–2024 and the base year 2025, and to forecast it for 2026–2032
To analyse the market by physical form and quantify the shift between powder and liquid methionine products
To assess demand for DL-methionine across poultry, swine and aquaculture & other livestock feed applications
To evaluate regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa
To identify the drivers, restraints, opportunities, trends and challenges influencing feed amino acid demand, including feed-protein economics and regulatory changes
To examine the value chain, from petrochemical raw materials and intermediates to feed mills and livestock producers
To analyse the competitive environment, including the positioning of leading producers and key developments since 2022
To assess the regulatory frameworks governing feed additives in major regions
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured process combining secondary research, primary research and analytical modelling. The process began with defining the market scope and segmentation, followed by extensive desk research to build an understanding of the DL-methionine value chain, production capacities, feed production volumes and trade flows. Hypotheses on market size and growth were then tested and refined through discussions with industry participants. Market estimates were derived using both top-down and bottom-up approaches, triangulated, and finally validated before the forecast was developed.
Stage 1 – Scoping: definition of the product, segmentation, geographies and timeline
Stage 2 – Secondary research: collection of data on feed production, livestock populations, amino acid inclusion rates, capacities, prices and trade
Stage 3 – Primary research: interviews with supply-side and demand-side participants to validate assumptions
Stage 4 – Market estimation: top-down and bottom-up sizing and data triangulation
Stage 5 – Forecasting and validation: projection of segment, regional and country values, and internal consistency checks
Secondary Research
Secondary research covered the following source types relevant to the DL-methionine and feed additives industry:
Industry associations: feed manufacturers' associations and poultry, swine and aquaculture producer associations at national and regional level, which publish compound feed production statistics and industry outlooks
Government and regulatory bodies: agricultural ministries, statistical offices, feed additive authorisation bodies and food safety agencies, including data on livestock inventories, meat production and feed additive approvals
International organisations: agricultural production, trade and outlook data from intergovernmental agencies
Company filings: annual reports, investor presentations, sustainability reports and press releases of methionine producers and their parent companies
Trade journals and industry publications: feed industry magazines and news services covering capacity announcements, pricing and regulation
Trade databases: import and export statistics for methionine under the relevant customs codes
Paid databases: commercial company, chemical pricing and agricultural market databases
Primary Research
Primary research was conducted to validate secondary findings, fill data gaps and gain qualitative insight into market dynamics. Interviews were carried out by telephone, video call and e-mail with participants across the value chain.
Supply side: methionine producers, distributors and traders, premix and feed additive companies, and raw material suppliers
Demand side: compound feed manufacturers, integrated poultry and swine producers, aquafeed producers, animal nutritionists and feed formulation consultants
The objectives of primary research were to validate market size and segment splits, understand the adoption of powder and liquid forms by customer type, assess pricing trends and procurement practices, gauge the impact of new capacity and raw material disruptions, and obtain views on the medium-term outlook for each region.
Market Size Estimation
Top-down approach: the global market was estimated from overall feed amino acid consumption and the share attributable to methionine, cross-checked against the installed production capacity and reported operating rates of leading producers. The global value was then allocated to segments, regions and countries using shares derived from secondary data and primary interviews.
Bottom-up approach: country-level demand was built up from compound feed production by livestock type, multiplied by typical methionine inclusion rates per tonne of feed and by average market prices. Country values were aggregated to regional and global totals.
Data triangulation: results from the top-down and bottom-up approaches were compared and reconciled with trade data and company information. Where differences arose, assumptions were reviewed with industry participants until the estimates converged.
Forecasting Methodology
The forecast was developed by projecting the demand-side drivers of methionine consumption and combining them with price expectations. Factors considered include:
Projected growth in poultry, pork and aquaculture production and compound feed output by region
Trends in amino acid inclusion rates linked to low-protein diet adoption and feed formulation practices
Raw material and energy price developments and their effect on methionine prices
Capacity additions, plant closures and supply disruptions
Regulatory changes affecting feed additives, antibiotic use and environmental emissions
Macroeconomic indicators such as population, income growth and urbanisation
Segment and regional forecasts were reconciled with the global total so that all segmentations sum to the overall market in every year.
Base Year, Forecast Period and Currency
Assumptions and Limitations
Values are expressed in current US dollars; exchange-rate effects are reflected in the conversion of local-currency data at average annual rates
No major disruption to global feed and livestock trade beyond those already observed is assumed for the forecast period
Regulatory frameworks for feed additives are assumed to remain broadly stable, with continued restrictions on antibiotic growth promoters
Methionine prices are cyclical and sensitive to capacity changes and raw material costs; short-term price movements may cause actual annual values to deviate from the forecast trend
Liquid methionine products are accounted for on a market value basis; differences in methionine activity between product forms are not separately adjusted
Information on privately held producers is limited, and some company data are based on public disclosures and secondary sources
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global DL-methionine market is highly consolidated. Production requires world-scale plants integrated with hazardous intermediates, and the leading producers – Evonik Industries, Adisseo, Novus International and Sumitomo Chemical – have historically accounted for most of the world's capacity. Since the early 2020s, Chinese producers such as Zhejiang NHU, Sichuan Hebang and Ningxia Unisplendour Tianhua have expanded rapidly, making the supply side more competitive. CJ CheilJedang offers fermentation-based L-methionine, and Volzhsky Orgsynthese supplies the Russian market. Trading houses such as ITOCHU play an important role in global distribution.
Competition is primarily based on cost position, which depends on scale, backward integration and access to low-cost raw materials and energy, as well as reliability of supply, logistics, technical service to feed formulators and the breadth of product portfolios across powder, liquid and specialty methionine. Pricing is cyclical and strongly influenced by capacity additions and raw material disruptions, as illustrated by the price increases announced across the industry in 2026.
Key Player Positioning
Market leaders: Evonik Industries and Adisseo are the leading global producers. Evonik, headquartered in Essen, Germany, reported group sales of EUR 14.1 billion in FY2025; it markets DL-methionine under the MetAMINO brand and rumen-protected methionine under the Mepron brand, from integrated production hubs in Singapore, Mobile (U.S.) and Antwerp (Belgium), with a global MetAMINO capacity of over 700,000 tonnes per year. Adisseo, controlled by China National BlueStar, reported operating revenue of RMB 17.231 billion in FY2025; it is one of the few producers of both powder (Rhodimet NP99) and liquid (Rhodimet AT88) methionine, with plants in France, Spain and China, and offers rumen-protected methionine under the Smartamine and MetaSmart brands.
Challengers: Novus International, owned by Mitsui & Co. and Nippon Soda, is a leading supplier of liquid methionine hydroxy analogue (ALIMET) and dry MHA; as a privately held company it does not publicly report revenue. Sumitomo Chemical (sales revenue of JPY 2,328.5 billion in FY2025, ended March 2026) produces methionine at Ehime Works in Japan and, since April 2025, sells its entire methionine output through ITOCHU Corporation (revenue of JPY 14,823.1 billion in FY2025, ended March 2026), which distributes the product in more than 70 countries. Zhejiang NHU (operating revenue of RMB 22.251 billion in FY2025) has become a major producer of both solid and liquid methionine, the latter in cooperation with Sinopec Zhenhai Refining & Chemical.
Niche and regional players: CJ CheilJedang (consolidated revenue of KRW 27.34 trillion in FY2025, with its Bio business at KRW 3.96 trillion) produces fermentation-based L-methionine at Kerteh, Malaysia, alongside Arkema's methyl mercaptan production. Sichuan Hebang Biotechnology (operating revenue of RMB 7.188 billion in FY2025) produces liquid methionine and has received approval for a large new methionine project. Ningxia Unisplendour Tianhua Methionine, part of the Chongqing Unisplendour Chemical group, operates DL-methionine production in Ningxia, China. Volzhsky Orgsynthese is Russia's only feed methionine producer, focused on the domestic market.
Competitor Dashboard
The competitor dashboard below rates each profiled company on four parameters relevant to competitiveness in the DL-methionine market. The ratings are qualitative analyst assessments.
Threat of New Entrants – Low
Production requires very high capital investment in world-scale, integrated plants and the handling of hazardous intermediates such as hydrogen cyanide and acrolein
Process know-how, intellectual property and access to raw material integration are concentrated among established producers
Recent entry has come mainly from established chemical companies in China with existing infrastructure, rather than from new independent players
Bargaining Power of Suppliers – Medium
Key inputs such as propylene, methanol and natural gas are commodities available from many suppliers, but their prices are volatile
Integrated producers make most intermediates in house, which reduces dependence on external suppliers
Non-integrated producers depend on a small number of local suppliers of intermediates, as seen in the precursor shortages of 2026
Bargaining Power of Buyers – High
Large feed manufacturers and integrators purchase large volumes and negotiate contracts with several suppliers
DL-methionine is a standardised product, and buyers can switch between producers and between powder, liquid and L-methionine sources based on price per unit of methionine activity
Buyers can partially adjust inclusion rates in response to relative prices of methionine and protein meals
Threat of Substitutes – Low
Methionine is an essential amino acid with no functional substitute in animal nutrition
Natural protein sources such as fishmeal and soybean meal can supply methionine only at higher crude protein levels and higher cost
Alternative forms such as methionine hydroxy analogue and L-methionine are part of the same competitive space rather than external substitutes
Intensity of Competitive Rivalry – High
A small number of large producers compete on price for a commodity product, and capacity additions in China have intensified competition
Price cycles are pronounced, and producers compete on cost position, reliability of supply and technical service
Producers differentiate through liquid and specialty products, logistics, and sustainability credentials
Threat of New Entrants: Low; High capital intensity, hazardous chemistry and process know-how.
Bargaining Power of Suppliers: Medium; Commodity inputs with volatile prices; mitigated by backward integration.
Bargaining Power of Buyers: High; Large, price-sensitive buyers of a standardised product.
Threat of Substitutes: Low; Essential nutrient with no functional substitute.
Intensity of Competitive Rivalry: High; Concentrated producers, capacity additions and cyclical pricing.
Market estimates by geography (2032)
InsightAsia Pacific leads with $41.66M by 2032, while Middle East & Africa is projected to grow fastest at a 5.4% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $11.53M | $13.54M | $16.03M | 3.3% | 17% |
| Europe | $11.64M | $13.47M | $15.86M | 3.1% | 17% |
| Asia Pacific | $25.37M | $32.71M | $41.66M | 5.1% | 44% |
| Latin America | $9.73M | $12.43M | $15.80M | 5.0% | 17% |
| Middle East & Africa | $3.59M | $4.70M | $6.07M | 5.4% | 6% |
| Total | $61.87M | $76.85M | $95.42M | 4.4% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$95.42M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Powder | $84.91M | 4.2% | 89% |
| Liquid | $10.52M | 6.0% | 11% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on DL-Methionine Market covering market dynamics, competitive landscape, and strategic outlook.
The DL-Methionine Market market is projected to reach $95.42M by 2032, growing at 4.4% CAGR. The Powder segment holds the largest share.
The DL-methionine market is shaped by forces operating at two levels. At the macro level, population and income growth, the global shift towards poultry and aquaculture protein, feed raw material prices and regulation of antibiotic use determine the volume of feed produced and the intensity of amino acid supplementation. At the micro level, feed formulation practices, the adoption of liquid dosing, competition between producers and animal disease outbreaks influence demand and pricing. This chapter assesses these factors and identifies the key drivers, restraints, opportunities, trends and challenges for the period 2026–2032.
Market Growth Factor Analysis
The following table presents five macro and five micro factors influencing the market, together with their impact type and an impact score on a scale of 1 to 10 for three periods within the forecast horizon. The impact scores are analyst assessments based on secondary research and industry discussions, where a higher score denotes a stronger influence on the market in the respective period.
Growing Global Demand for Poultry Meat and Eggs
Poultry is the fastest-growing major source of animal protein worldwide. It is affordable, faces few religious or cultural restrictions, has a short production cycle and the most efficient feed conversion among land livestock. International agricultural outlooks from the OECD and FAO consistently project poultry to account for the largest share of the increase in global meat consumption over the coming decade, with most of the growth concentrated in Asia, Latin America and Africa. Because methionine is usually the first limiting amino acid in corn–soybean meal broiler and layer diets, every additional tonne of poultry feed creates direct demand for DL-methionine. Integrated poultry companies in Brazil, China, India, Southeast Asia and the Middle East have continued to invest in new broiler and layer capacity and in modern feed mills, where precise amino acid supplementation is standard practice. This is reflected in the Poultry segment, which is projected to grow from USD 45.81 million in 2025 to USD 61.50 million in 2032.
Shift to Low-Protein, Amino-Acid-Balanced Diets
Feed formulators increasingly reduce the crude protein content of diets and meet requirements for individual essential amino acids with synthetic sources. This approach lowers dependence on expensive and import-dependent protein meals, reduces nitrogen excretion and ammonia emissions from livestock housing, and can improve gut health. Environmental regulations on nitrogen and ammonia in Europe and growing attention to the carbon footprint of animal protein are encouraging this practice, while feed-cost pressure has accelerated it in Asia and Latin America. National programmes to reduce soybean meal use in feed, such as those promoted by Chinese agricultural authorities in recent years, have further raised interest in crystalline amino acids. As protein levels fall, methionine, lysine, threonine and other amino acids must be added in greater quantities and with greater precision, structurally increasing DL-methionine use per tonne of feed.
Expansion of Aquaculture
Aquaculture has become the main source of growth in global aquatic animal production; according to FAO, aquaculture surpassed capture fisheries in aquatic animal production for the first time in 2022. As fishmeal supply is limited and costly, aquafeed producers replace it with plant proteins such as soybean meal, corn gluten and rapeseed meal, which are naturally low in methionine. Supplementing these diets with methionine is necessary to maintain growth and feed efficiency in shrimp and fish such as tilapia, pangasius, salmon and carp. Growth of shrimp and fish farming in China, India, Vietnam, Indonesia, Ecuador and Norway is therefore a significant source of incremental demand. The Aquaculture & Others segment is expected to grow at a CAGR of 5.31% during 2026–2032, faster than any other livestock segment.
Restrictions on Antibiotic Growth Promoters and Focus on Animal Performance
The European Union banned the use of antibiotics as growth promoters in feed from 2006, and China prohibited growth-promoting antibiotics in feed from 2020, while other countries have tightened rules on antimicrobial use in livestock. Without antibiotic growth promoters, producers rely more heavily on precise nutrition to maintain performance, gut health and feed efficiency. Optimised amino acid profiles, including adequate methionine and cysteine for immune function and antioxidant capacity, form part of this nutritional strategy. At the same time, the genetic potential of modern broiler, layer and pig lines continues to rise, increasing the absolute requirement for digestible amino acids. Together, these factors support stable growth in the use of DL-methionine across all major livestock categories.
Growth of Liquid Methionine in Integrated Feed Mills
Large feed mills and integrators increasingly install automated liquid dosing systems, which allow accurate inclusion of liquid methionine, reduce dust and handling costs, and simplify logistics through bulk tanker delivery. The Liquid segment is projected to grow from USD 7.05 million in 2025 to USD 10.52 million in 2032, at a CAGR of 5.83%. Producers with liquid capacity, such as Adisseo, Novus International, Zhejiang NHU and Sichuan Hebang, can benefit from this trend through supply contracts, dosing equipment and technical support for feed mills converting to liquid systems.
Emerging Markets in Asia, Latin America and Africa
Per capita consumption of animal protein in India, Southeast Asia, Sub-Saharan Africa and parts of Latin America remains well below that of developed markets, and commercial poultry and aquaculture production in these regions is growing rapidly. The shift from backyard to commercial farming increases the use of compound feed and, in turn, amino acid supplementation. India is the fastest-growing country market in this study, with a CAGR of 6.71%, and Middle East & Africa is the fastest-growing region, with a CAGR of 5.27%. Building distribution networks, local technical service and partnerships with regional feed producers can unlock this demand.
Specialty and Rumen-Protected Methionine
Dairy cows have a methionine requirement that cannot be met with unprotected DL-methionine, because it is degraded in the rumen. Rumen-protected methionine products allow methionine to bypass the rumen and are used to improve milk protein yield and transition-cow health. Producers such as Evonik and Adisseo offer rumen-protected ranges, and growth in high-yield dairy herds offers an avenue for value-added products. Further opportunities exist in methionine products with a lower carbon footprint, supported by backward integration and process optimisation, as feed buyers begin to account for scope 3 emissions.
Raw Material Price Volatility and Supply Risks
DL-methionine production relies on petrochemical and industrial gas inputs, including propylene, methanol, natural gas, ammonia, sulfur or hydrogen sulfide, and hydrogen cyanide. Prices of these inputs fluctuate with crude oil, gas and refinery markets, and some intermediates are produced in only a limited number of integrated sites. Supply disruptions or price spikes in any of these materials affect production costs and availability. In 2026, disruptions to raw material supply linked to the conflict in the Middle East constrained precursor availability, and leading producers announced price increases for methionine. Such volatility complicates feed cost planning for customers and can temporarily reduce inclusion rates when methionine becomes expensive relative to protein meals.
Cyclical Pricing and Risk of Overcapacity
Methionine is a commodity with a concentrated producer base and lumpy, large-scale capacity additions. New plants typically have capacities of 100,000–300,000 tonnes per year, so each start-up can shift the supply–demand balance and lead to sharp price declines. Significant new capacity has been commissioned or announced in China since 2022, which intensifies price competition and pressures margins, particularly for older, higher-cost plants in Europe and Japan. Periods of low prices reduce the value of the market even when volumes grow.
Animal Disease Outbreaks
Outbreaks of highly pathogenic avian influenza and African swine fever have periodically reduced poultry and pig populations in major producing countries. African swine fever caused a large decline in China's pig herd from 2018 to 2020, and avian influenza has led to the culling of large numbers of laying hens and broilers in the United States, Europe and other regions in recent years. Such outbreaks reduce feed demand and introduce uncertainty into regional consumption of DL-methionine.
Capacity Expansion and Shift of Production to China
Chinese producers have rapidly expanded DL-methionine capacity. Zhejiang NHU reported solid methionine capacity of 370,000 tonnes per year and liquid capacity of 180,000 tonnes per year in March 2026, Adisseo is building a 150,000 tonne per year solid methionine plant in Quanzhou, and Sichuan Hebang has received project approval for a large new methionine project. This shift is changing trade flows, reducing China's import dependence and increasing exports from China to other markets.
Backward Integration and Network Optimisation
Leading producers are integrating backwards into key intermediates such as methyl mercaptan and MMP to reduce costs, improve supply security and lower carbon footprint. Evonik completed backward integration across its three MetAMINO production hubs in 2026, while Adisseo consolidated European powder production at Roches-Roussillon in France. Network optimisation, debottlenecking and the closure of older plants are expected to continue as producers respond to cost competition.
Supply Disruptions and Price Volatility in 2026
The year 2026 has been marked by tight supply. Disruptions to raw material availability linked to the conflict in the Middle East affected precursor supply, Evonik announced a 10% increase in its global MetAMINO price in March 2026, and other producers adjusted prices for methionine and specialty products. Chinese producers reported notable price increases from March 2026. Such volatility is a challenge for feed producers and livestock integrators, which must manage feed cost budgets and secure supply through longer-term contracts.
Precision Nutrition and Sustainability Requirements
Feed producers increasingly use near-infrared analysis of raw materials, digestible amino acid databases and formulation software to fine-tune amino acid levels. Retailers and food companies are also setting targets for emissions and nitrogen reduction in their supply chains. These trends favour suppliers that combine product supply with analytical services, life-cycle assessment data and technical support, while increasing the scrutiny of the environmental profile of methionine production.
The DL-methionine value chain consists of four main stages, from petrochemical raw materials to livestock producers.
Raw materials and intermediates: Propylene is oxidised to acrolein; methanol and hydrogen sulfide are reacted to methyl mercaptan; and natural gas, ammonia and methane are used to make hydrogen cyanide. Acrolein and methyl mercaptan combine to form MMP, the central intermediate. Because these substances are hazardous and difficult to transport, leading producers make most of them on site.
Manufacturing: MMP is converted via the hydantoin route into crystalline DL-methionine, or via the cyanohydrin route into methionine hydroxy analogue for liquid products. Production takes place in large, capital-intensive plants located at a limited number of chemical hubs in Europe, the United States, Asia and Russia. Fermentation-based L-methionine production represents an alternative route.
Distribution and channels: Producers sell directly to large feed manufacturers and integrators under annual or multi-year contracts, and through distributors, trading houses and premix companies to smaller feed mills and farms. Powder is shipped in bags and big bags; liquid products are shipped in bulk by tanker and stored in tanks at feed mills.
End users: Compound feed manufacturers, premix producers, integrated poultry and swine companies, aquafeed producers and dairy nutrition companies incorporate DL-methionine into feed for broilers, layers, pigs, fish, shrimp, ruminants and pets.
DL-methionine is regulated as a feed additive or feed ingredient in all major markets. Producers must also comply with chemical safety, environmental and occupational health regulations relating to manufacturing.
Sep 2022: Adisseo; Expansion; Started operation of its 180,000 tonne per year liquid methionine plant in Nanjing, China.
Jan 2023: Zhejiang NHU; Partnership; Announced a methionine project with Sinopec Zhenhai Refining & Chemical (ZRCC) in Ningbo, China.
Apr 2023: Evonik Industries; Restructuring; Divided its Animal Nutrition business into separate amino acids and specialty nutrition businesses, targeting annual savings of EUR 200 million.
Aug 2023: Adisseo; Expansion; Announced a 150,000 tonne per year solid methionine plant in Quanzhou, Fujian, China, with an investment of RMB 4.9 billion.
Jan 2024: Adisseo; Consolidation; Permanently ended DL-methionine production at Commentry, France, consolidating European powder production at Roches-Roussillon.
Mar 2024: Novus International; Acquisition; Completed the acquisition of enzyme producer BioResource International.
Jun 2024: Novus International; Facility; Opened a new global headquarters and research laboratory in Chesterfield, Missouri, U.S.
Aug 2024: Evonik Industries; Expansion; Completed the expansion of its MetAMINO plant in Singapore by 40,000 tonnes to 340,000 tonnes per year.
Aug 2024: JSC Volzhsky Orgsynthese; Ownership; Russian government order set a closed auction for 100% of the company's shares following transfer to state control.
Feb 2025: Sumitomo Chemical, ITOCHU; Partnership; Agreed a comprehensive partnership under which ITOCHU sells all of Sumitomo Chemical's methionine from April 2025.
Mar 2025: Evonik Industries; Investment; Announced an upgrade of its Antwerp and Wesseling MetAMINO production network.
Apr 2025: CJ CheilJedang; Strategy; Ended the sale process for its Bio business and decided to retain and develop it.
Jun 2025: Novus International; Restructuring; Reorganised into a Methionine Business Unit and a Specialty Business Unit.
Jun 2025: Zhejiang NHU; Expansion; Reported 300,000 tonnes per year of solid methionine capacity, with its 180,000 tonne per year liquid methionine unit with Sinopec ZRCC in trial production.
Mar 2026: Evonik Industries; Pricing; Announced a 10% increase in its global MetAMINO price.
Apr 2026: Adisseo; Pricing; Announced a worldwide price adjustment for its SmartLine rumen-protected products, effective 1 May 2026.
Apr 2026: Sichuan Hebang; Expansion; Reported project approval for a new large-scale methionine project in its FY2025 annual report.
Jul 2026: Evonik Industries; Expansion; Started on-site methyl mercaptan production in Mobile, U.S., completing backward integration of all three MetAMINO hubs.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 29 companies operating in the DL-Methionine Market market, including revenue, employee count, and market positioning where available.
Showing 29 of 29 companies
Evonik is Germany's second-largest listed chemicals group after BASF and one of Europe's broadest pure-play specialty chemicals companies, generating €14.1bn of sales and €1.87bn adjusted EBITDA in FY2025. Since April 2025 it has been organised into two operating segments — Custom Solutions (formulated, application-driven specialties for coatings, personal care, pharma, and industrial additives) and Advanced Technologies (scale- and technology-driven platforms in silica, hydrogen peroxide, high-performance polymers, crosslinkers and animal-nutrition amino acids) — plus an Infrastructure segment (SYNEQT site services, Oxeno C4 chemicals) earmarked for divestment. Its competitive identity rests on deep process know-how, integrated German Verbund sites (Marl, Wesseling, Rheinfelden, Essen, Hanau), and leadership positions in global niches (fumed silica, DL-methionine, PA12, pharma excipients/lipids). The investment case is a transformation story — €400m-plus cost reduction, portfolio pruning, deleveraging — now overlaid by a live takeover approach from BASF and a near-majority foundation shareholder whose stance is pivotal. --- ### Company self-description Evonik describes itself as a global chemical company that goes "beyond chemistry" by combining innovative strength with leading technological expertise, providing customers with a competitive advantage through tailor-made products and solutions — positioning itself as a "superforce for industry" (company boilerplate, press releases 2026; Company Factbook 2026). Its stated strategic pillars (Capital Markets Day, 22 May 2025) are: a differentiated portfolio in two segments, sustainable innovation, a balanced regional footprint (ambition of roughly one-third of sales in each of Americas, EMEA and Asia-Pacific), and a performance culture. ### Independent characterisation Evonik is a mid-cap, diversified specialty and "semi-specialty" chemicals manufacturer. Roughly 80% of FY2025 sales (€11.5bn of €14.1bn) came from the two core segments; the remaining ~18–19% came from Infrastructure & Other, which bundles low-margin site services and the cyclical C4 (Oxeno) petrochemical chain. The business is overwhelmingly a product business (manufactured chemicals sold B2B under supply contracts, frame agreements and spot), with smaller service/contract components: (i) pharma CDMO and contract manufacturing (Health Care — lipids/LNPs, drug substances, oral drug delivery), (ii) site infrastructure and utility services sold by SYNEQT to ~two dozen third-party companies in the Marl and Wesseling chemical parks, and (iii) licensing/technology (e.g., HPPO hydrogen peroxide technology with partners; catalysts). Subscription revenue is negligible. Precise revenue-model split (product vs service vs licensing) is n/d. ### Value-chain position Evonik sits mid-stream: it buys petrochemical feedstocks (C4 raffinate, propylene, methanol, ammonia, natural gas/energy, silicon metal, sulphur) and converts them into intermediates and formulated specialties sold to formulators and OEMs. Upstream integration is partial (own C4 cracking downstream of refinery/cracker streams at Marl and Antwerp; own HCN and methionine chain in Antwerp, Mobile and Singapore). Downstream, it rarely sells to consumers; its products are ingredients typically <5% of the customer's cost but critical to performance ("small cost share, high value-in-use"), which supports pricing power in the specialty businesses. ### Customer types and end markets Customers include paint and coatings formulators, adhesives and sealants makers, tyre and rubber producers (silica/silanes), cosmetic and household-care brands, pharmaceutical and biotech companies (excipients, lipids, CDMO), animal-feed mills and integrators (methionine), plastics and automotive suppliers (PA12, PEEK), aerospace (ROHACELL foams), pulp & paper, electronics and semiconductors (high-purity silanes/chlorosilanes, H2O2), renewable energy and hydrogen (membranes, catalysts), and biodiesel producers (alkoxide catalysts). End-market exposure is broad: consumer/personal care, health care, food/feed, automotive and mobility, construction, coatings, industrial, energy/agriculture. A precise end-market % split for FY2025 is n/d in sources reviewed.
Company Headquarters: Missouri, US Founded: 1991 Workforce: ~800+ Company Working: Novus International manufactures animal health and nutrition products for livestock, poultry, and aquaculture. The products offered by the company include various preservative premixtures, feed supplements, feed additives, nutritional feed acids, chelated trace minerals, feed preservatives, feed antioxidants, and other specialty ingredients. Under its eubiotics products category, the company offers ACIDOMIX, a uniquely formulated blend of organic acids which ensures delivery of its acidification to the lower digestive tract. In addition to its preserving effects, the product has antimicrobial effects that help reduce bacterial contamination levels and energy waste resulting in optimal growth rates. The company has research & development laboratories and manufacturing facilities in more than 35 countries, as well as offices with field staff in an additional 60 countries. Novus International operates as a subsidiary of Mitsui & Co. (U.S.A.) Inc. and Nippon Soda Co., Ltd.
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
RPM International is a holding company for more than a dozen semi-autonomous specialty-chemicals franchises. These businesses make coatings, sealants, roofing, concrete admixtures, flooring, fireproofing and building-envelope systems, mostly for maintenance, repair and restoration rather than new construction. Its brand portfolio is unusually deep for a USD 7.9 billion company: Rust-Oleum, DAP, Zinsser, Varathane and The Pink Stuff on the consumer side; Tremco, Euclid, Dryvit, Nudura, Kalzip, Stonhard, Carboline and Fibergrate on the professional side. Each brand holds a leading position in a niche that larger diversified coatings groups do not dominate. Since 2018 RPM has run successive operational-improvement programs (MAP to Growth, MAP 2025, and now "MAP 3.0"). These have lifted gross margin from about 36% (FY2022) to about 41% (FY2026) and moved the group from a loose federation toward a centrally coordinated operating company. RPM is a disciplined, dividend-growing compounder with 52 consecutive annual dividend increases. Its growth vectors are engineered building systems, emerging markets (the "Platform" model) and bolt-on M&A. --- ### Company's own description (FY2026 Form 10-K, Item 1) RPM describes itself as follows: its subsidiaries manufacture, market and sell specialty chemical product lines, including high-quality specialty paints, infrastructure rehab and repair products, protective coatings, roofing systems, sealants and adhesives. These products focus on the maintenance and improvement needs of the construction, industrial, specialty and consumer markets. Footprint as of 31 May 2026: - Products marketed in about 167 countries and territories. - Manufacturing in about 120 locations across 22 countries. - About 31% of sales generated internationally: foreign operations 29.8% of net sales, plus direct U.S. exports of 0.9%. The press-release boilerplate calls RPM "a world leader in specialty coatings, sealants, building materials and related services." ### Business model RPM's model has four defining features. - **Decentralised entrepreneurial structure, becoming more integrated.** The founder's philosophy, still quoted in the 2026 proxy, is: "Hire the best people you can find. Create an atmosphere that will keep them. Then let them do their jobs." Operating companies historically kept their own brands, sales forces and ERP systems. The MAP programs are deliberately centralising procurement, manufacturing, accounting and IT. The stated goal is to consolidate more than 75 ERP systems to one platform per segment (Q4 FY2026 8-K). **Repair and maintenance bias:** Much of the portfolio serves existing assets: roof restoration, re-cover, concrete repair, corrosion control, rust prevention and DIY touch-up. That demand is less cyclical than new-build construction. The FY2026 10-K notes that re-roofing has historically accounted for over three-quarters of U.S. roofing demand. **Systems and turnkey selling:** In CPG and PCG, RPM increasingly sells integrated systems (the "Power of One" building envelope) and supply-and-apply turnkey services. Examples include Stonhard flooring installation and Weatherproofing Technologies roofing services. This captures more of each construction project's spend. **Bolt-on M&A plus organic growth:** RPM completed six acquisitions in each of FY2025 and FY2026 (FY2026 10-K Note F). ### Revenue model mix | Revenue type | Characterisation | Evidence | |---|---|---| | Product sales | Dominant (estimated well above 90% of revenue; exact split not publicly disclosed) | Manufactured coatings, sealants, admixtures and similar products sold through retail, distribution and direct channels | | Installation and services | Material within CPG and PCG; not separately disclosed | WTI/WTC roofing services, turnkey general contracting, TremCare maintenance programs, Stonhard installed flooring, Legend Brands/RoofTec restoration services, Pure Air Control Services | | Warranty and extended programs | Embedded in pricing; generates deferred revenue | Current unearned revenue USD 75.3M and long-term unearned revenue USD 92.4M at FY2026 (standardized balance sheet) | | Licensing and royalties | Minor | The 10-K notes license fees and royalty income from numerous international license agreements, plus equity-method joint ventures | | Subscription | None identified | — | RPM does not disclose a product versus service versus licensing split. From filings, the mix is: ### Value-chain position RPM is a formulator and brand owner, positioned downstream of commodity chemical producers. It buys petroleum-derived resins, solvents, pigments, minerals, metals and packaging (FY2026 10-K, Raw Materials). It is selectively backward-integrated: RPM cites expanding in-house raw material production, and Arnette Polymers makes amine curing agents and epoxy intermediates. Channels downstream include: - Mass merchants and home centres, where the single largest Consumer customer was 20% of Consumer sales in FY2026. - Hardware and paint stores. - Distributors. - Contractors and specifiers. - Direct sales to industrial plant owners, public institutions and infrastructure agencies. ### Customer types and end markets | End market | Segment exposure | Representative brands | |---|---|---| | Commercial / institutional building envelope (roofing, walls, waterproofing, sealants) | CPG | Tremco, Dryvit, Nudura, illbruck, Kalzip, Volteco | | Concrete, cement and infrastructure | CPG, PCG | Euclid, Toxement, Viapol, Prime Resins, Fibrecrete | | Industrial maintenance, oil and gas, petrochemical, power, data centres | PCG | Carboline, Stonhard, Fibergrate, Nullifire | | Food and pharma | PCG | Mantrose-Haeuser, NatureSeal, Profile Food Ingredients | | Marine, wood finishes, powder coatings | PCG | Pettit, Woolsey, FinishWorks/Mohawk, TCI | | Residential DIY and professional painters | Consumer | Rust-Oleum, Zinsser, Varathane, DAP | | Household cleaning | Consumer | The Pink Stuff, Krud Kutter, Mean Green | | Pigments, colorants, OEM and personal care | Consumer (Color Group) | Day-Glo | | Restoration services equipment | CPG (Legend Brands) | Dri-Eaz, Sapphire Scientific | ### Independent characterisation RPM is best understood as a portfolio of niche category leaders with a structural margin-improvement story layered on top. The professional segments (CPG and PCG) are about 66% of sales and supply the growth. In FY2026 they posted record results driven by high-performance buildings, data centres, infrastructure, fireproofing and concrete admixtures. In Q1 FY2027, emerging-market regions grew more than 20%. The Consumer segment is about 34% of sales. It is a cash-generative but volume-challenged DIY business. Organic Consumer sales fell 0.8% in Q4 FY2026 and 4.7% in Q2 FY2026. They recovered to +5.2% in Q1 FY2027 on shelf-space wins and pricing. The equity debate therefore centres on three questions: 1. Can MAP savings and pricing protect margins against renewed raw-material inflation linked to the Middle East conflict? 2. Is the Q1 FY2027 CPG slowdown temporary? 3. Will the 9 November 2026 investor day credibly frame the next margin plan?
58 interactive charts drawn from the DL-Methionine Market dataset — market size, each segment breakdown, and every region and country by segment. Open one to read its full data table and download it.
Global DL-Methionine Market By Region
Global DL-Methionine Market By Physical Form
Global DL-Methionine Market By Livestock
Global DL-Methionine Market — North America by Country
Global DL-Methionine Market — North America by Livestock
Global DL-Methionine Market — North America by Physical Form
Global DL-Methionine Market — U.S. by Livestock
Global DL-Methionine Market — U.S. by Physical Form
Global DL-Methionine Market — Canada by Livestock
Global DL-Methionine Market — Canada by Physical Form
Global DL-Methionine Market — Mexico by Livestock
Global DL-Methionine Market — Mexico by Physical Form
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and forecast (2022–2032, USD Million)
Market Size (USD Million)
